CompuGroup Medical Partners with CVC Capital Partners

Shares of CompuGroup Medical (ETR:COP1n) soared over 31% on Monday following a partnership agreement with Luxembourg-based private equity firm CVC Capital Partners.

Tender Offer Details

CVC plans to launch a voluntary public tender offer for the company's outstanding shares at €22.00 per share, representing a premium above recent trading prices: 51.1% over the volume-weighted average share price in the last three months and 33.5% above the closing price as of Friday.

This tender offer aims to offer immediate value realization for shareholders while fostering CompuGroup Medical’s long-term growth strategy.

Growth and Innovation

Daniela Hommel, CFO of CompuGroup Medical, stated that this partnership will allow the company to pursue greater growth opportunities, focusing on inorganic growth, cloud-based products, and AI solutions.

The company, which provides software for healthcare providers globally, intends to expand its reach and enhance product offerings through this collaboration.

Stakeholder Commitment

Key shareholders, including the founding Gotthardt family and Dr. Reinhard Koop, will retain their majority stake, holding 50.1% of the company's shares. Frank Gotthardt will continue as Chairman of the Administrative Board, with Daniel Gotthardt as CEO.

Regulatory Considerations

CVC's tender offer is contingent on acquiring at least 17% of the free-floating shares and gaining regulatory approvals, including antitrust clearance. Upon completion, CVC and its partners will hold at least 67% of the company's shares, with plans for a subsequent delisting of CompuGroup Medical, expected to be finalized in the first half of 2025.

The acceptance period for the tender offer is slated to begin later this month, pending approval from the German Federal Financial Supervisory Authority.